0001209191-23-000986.txt : 20230104 0001209191-23-000986.hdr.sgml : 20230104 20230104163938 ACCESSION NUMBER: 0001209191-23-000986 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230103 FILED AS OF DATE: 20230104 DATE AS OF CHANGE: 20230104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GROVES REGINA E CENTRAL INDEX KEY: 0001653877 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37894 FILM NUMBER: 23507164 MAIL ADDRESS: STREET 1: 5751 COPLEY DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92111 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Fulgent Genetics, Inc. CENTRAL INDEX KEY: 0001674930 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 812621304 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4978 SANTA ANITA AVENUE, SUITE 205 CITY: TEMPLE CITY STATE: CA ZIP: 91780 BUSINESS PHONE: 626-350-0537 MAIL ADDRESS: STREET 1: 4978 SANTA ANITA AVENUE, SUITE 205 CITY: TEMPLE CITY STATE: CA ZIP: 91780 FORMER COMPANY: FORMER CONFORMED NAME: Fulgent Diagnostics, Inc. DATE OF NAME CHANGE: 20160517 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-01-03 0 0001674930 Fulgent Genetics, Inc. FLGT 0001653877 GROVES REGINA E C/O FULGENT GENETICS, INC. 4978 SANTA ANITA AVE TEMPLE CITY CA 91780 1 0 0 0 Common Stock 2023-01-03 4 A 0 4000 0.00 A 4000 D Stock Option (Right to Buy) 30.66 2023-01-03 4 A 0 10000 0.00 A 2033-01-02 Common Stock 10000 10000 D Restricted stock units. The shares subject to the restricted stock units vest over a period of four years, with 1/4th of such shares vesting 12 months after January 3, 2023, and 1/16th of such shares vesting at the end of every three month period thereafter over the remaining 36 months, subject to the reporting person's continued service for Issuer on each vesting date. The shares subject to the option vest over a period of four years, with 1/4th of such shares vesting 12 months after January 3, 2023, and 1/16th of such shares vesting at the end of every three month period thereafter over the remaining 36 months, subject to the reporting person's continued service for Issuer on each vesting date. /s/ Paul Kim as Attorney-in-Fact 2023-01-04